SELLAS Life Sciences (SLS) Return on Capital Employed Growth (1y) (2013 - 2026)
SELLAS Life Sciences (SLS) Return on Capital Employed Growth (1y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
68,255.00 |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
2,665.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
31,429.00 |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
2,503.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
16,829.00 |
| 10 |
SELLAS Life Sciences |
1.39 Bn |
1.39 Bn |
- |
10,252.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
10,252.00 |
| Dec 31, 2025 |
18,534.00 |
| Sep 30, 2025 |
24,651.00 |
| Jun 30, 2025 |
35,178.00 |
| Mar 31, 2025 |
393,586.00 |
| Dec 31, 2024 |
-80,945.00 |
| Sep 30, 2024 |
213,864.00 |
| Jun 30, 2024 |
-9,561.00 |
| Mar 31, 2024 |
-368,975.00 |
| Dec 31, 2023 |
110,251.00 |
| Sep 30, 2023 |
-219,340.00 |
| Jun 30, 2023 |
-5,424.00 |
| Mar 31, 2023 |
-8,171.00 |
| Dec 31, 2022 |
-43,398.00 |
| Sep 30, 2022 |
-21,628.00 |
| Jun 30, 2022 |
-25,977.00 |
| Mar 31, 2022 |
-26,135.00 |
| Dec 31, 2021 |
-807.00 |
| Sep 30, 2021 |
12,382.00 |
| Jun 30, 2021 |
14,619.00 |
